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cytochrome c interacts with cardiolipin to 
form a complex (cyt. c/CL) important in 
apoptosis. Here we show that this 
interaction leads to structural changes in 
ferrocytochrome c that leads to an open 
coordinate site on the central iron, resulting 
from the dissociation of the intrinsic 
methionine residue, where NO can rapidly 
bind (k=1.2*107 M-1s-1). Accompanying NO 
binding the proximal histidine dissociates 
leaving the heme pentacoordinate, in 
contrast to the hexacoordinate nitrosyl 
adducts of native ferrocytochrome c or of 
the protein in which the coordinating 
methionine is removed by chemical 
modification or mutation. We present the 
results of stopped-flow and photolysis 
experiments that show that following initial 
NO binding to the heme there ensues an 
unusually complex set of kinetic steps. The 
spectral changes associated with these 
kinetic transitions, together with their 
dependencies on NO concentration, have 
been determined and lead us to conclude 
that NO binding to cyt. c/CL takes place via 
an overall scheme comparable to that 
described for cytochrome c’ and guanylate 
cyclase, the final product being one in which 
NO resides on the proximal side of the 
heme. In addition, novel features not 
observed before in other heme proteins 
forming pentacoordinate nitrosyl species, 
include a high yield of NO escape after 
dissociation, rapid (<1 ms) dissociation of 
proximal histidine upon NO binding and its 
very fast binding (60 ps) after NO 
dissociation, and the formation of a 
hexacoordinate intermediate. These features 
all point at a remarkable mobility of the 
proximal heme environment induced by 
cardiolipin. 
 
Nitric oxide (NO) is an important 
signalling molecule that plays a key role in a 
variety of biological processes including 
vasodilation, neuronal function, inflammation 
and immune function (1). Recently, it has been 
demonstrated that it is also involved in the 
regulation of apoptosis (programmed cell 
death), having a dual role, stimulatory in some 
cells and inhibitory in others, through 
mechanisms not fully elucidated (2, 3). Due to 
its hydrophobic nature, which enables easy 
diffusion in biomembranes (4, 5), NO can 
reach mitochondria, where it may also be 
produced by the recently discovered 
mitochondrial nitric oxide synthase (6, 7). It 
has been shown that during apoptosis NO 
nitrosylates the heme iron of mitochondrial 
cytochrome c (cyt. c), which is then rapidly 
released into the cytoplasm (8, 9), suggesting 
that NO may play a significant role in one of 
the key apoptotic events, the release of cyt. c 
(10). NO is a versatile ligand able to bind to 
both heme iron(II) and iron(III) states. It can 
give rise to 6-coordinate heme adducts as in 
myoglobin and hemoglobin with histidine and 
NO as distal axial ligands or to 5-coordinate 
heme adducts with NO as the axial ligand, as 
in sGC (guanylate cyclase) (11) and AXCP 
(cyt. c´ from Alcaligenes xylosoxidans) (12, 
13). In AXCP, it can bind to the proximal side 
of the heme replacing the endogenous 
proximal His (13, 14), suggesting that heme-
based sensor proteins may utilize both sides of 
their hemes for ligand discrimination.  
 Cyt. c is a small redox heme protein 
located in the mitochondrial intermembrane 
space (IMS), where it shuttles electrons 
between the complexes III (bc1 complex) and 
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IV (cytochrome c oxidase) of the respiratory 
chain. It bears a positive charge at pH values 
found in the IMS and thus interacts 
electrostatically with phospholipids bearing a 
net negative charge, such as cardiolipin (CL), a 
mitochondria specific phospholipid (15). 
Moreover, it has been suggested that cyt. c (in 
a fraction of the molecules) may also be 
anchored to the outer surface of the 
mitochondrial inner membrane by hydrophobic 
interactions with CL. Upon interaction with 
CL, cyt. c has been shown to alter its tertiary 
structure and to display a peroxidase activity 
that results in the oxidation of CL and 
subsequently in the permeabilization of the 
outer mitochondrial membrane (16). This gain 
of peroxidatic function by cyt. c upon 
interaction with CL has been the focus of 
intense research effort that has recently been 
reviewed by Kagan et al (17). 
 Our recent work has demonstrated that 
cyt. c in the presence of CL gains the capacity 
to bind CO rapidly and with high affinity, in 
sharp contrast to the CL-free protein (18). 
Furthermore, the CO dynamics of the cyt. c/CL 
complex indicate that significant 
conformational changes take place in the 
presence of CL, leading to the formation of 
channels that may facilitate the access of H2O2 
to the heme, enabling the peroxidase activity of 
the cyt. c/CL complex (18) and pointing 
towards a possible regulatory role for carbon 
monoxide. Such a regulatory role has also been 
proposed for nitric oxide, which has been 
shown to inhibit the peroxidase activity of the 
cyt. c/CL complex, with CL facilitating the 
interaction of cyt. c with NO (19).  
 Study of the NO binding dynamics can 
provide significant information about the heme 
environment, since these are closely related to 
the protein function and subtly controlled by 
the protein structure (20). In the present work, 
we investigated the NO release and binding 
dynamics, on timescales ranging from 
picoseconds to seconds, of the cyt. c/CL 
complex in order to gain further insight into 
the possible roles of NO in modulating cyt. 
c/CL-mediated apoptosis. We show that NO 
fully replaces the proximal histidine via an 
unusually complex set of kinetic steps, 
pointing at a remarkable mobility of the heme 
environment induced by CL. Our work implies 
that CL may contribute to a controlled NO 





Sample preparation- Cyt. c (horse heart) was 
purchased from Aldrich and dissolved in either 
20 mM MOPS pH=6.7 (femtosecond 
spectroscopy, similar results were obtained 
with 20 mM Hepes pH=7.4) or 20 mM Hepes 
pH=7.4 (all other spectroscopy), and final 
protein concentrations were typically between 
1 and 13 µM. Ferrous cyt. c/CL complexes (30 
CL/cyt. c) were prepared as described (18). For 
the femtosecond measurements, the cyt. c/CL 
complex was equilibrated with ~0.1 atm of 
pure NO gas. For all other experiments stock 
NO solutions were prepared using an NO 
donor called Proli-NONOate purchased from 
Alexis Biochemicals. The concentration of 
stock NO solutions was determined using an 
extinction coefficient of 8,500 M-1 cm-1 at 250 
nm. To study the reversibility of the process, 
returning the CL pentacoordinate nitrosyl 
adduct to the native cyt. c protein, CL was 
removed from the NO cyt. c/CL adduct by 
incubation (5 mins) with 250 mM NaCl 
(Sigma) and 10 mM Triton X-100 (Sigma), 
and the NO was removed by photolysis in the 
presence of the NO scavenger carboxy-PTIO 
(Alexis Biochemicals). The protein was 
separated from the mixture by elution from a 
cation ion exchange resin (CM-52, Sigma). 
The sample of the resulting protein was then 
diluted to a concentration comparable to that of 
a sample of native ferrous cyt. c for spectral 
comparison (see Results).  
Ferrous carboxymethyl (cm) cyt. c was 
prepared as described (21).  
 
Spectroscopy- Steady-state spectra were 
recorded using either a Shimadzu UV-Vis 
1601 or Varian CARY 5E spectrophotometer. 
Multicolor femtosecond absorption 
spectroscopy using 60 fs pulses centred at 560 
nm and white light continuum probe pulses in 
the 380-480 nm region, at a repetition rate of 
30 Hz, and data analysis was performed as 
described (22). Stopped-flow spectroscopy was 
carried out using an Applied Photophysics SX-
20 instrument. In order to obtain high quality 
data over a spectral range (here 380-450 nm) 
we did not employ a diode array for the 
experiments reported here, but instead 
accumulated kinetic traces using 
photomultiplier detection at 2 nm intervals 
throughout the wavelength range explored and 
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used the whole data set to construct the time 
resolved spectra. Thus each experiment 
required 36 individual “shots” which on 
assembly yielded kinetic data points at 25 µs 
intervals (for the fastest time courses) and at 2 
nm intervals on the wavelength scale. 
Microsecond laser flash photolysis 
measurements were carried out on an Applied 
Photophysics SX.18MV instrument. All optical 
spectroscopic measurements were performed at 
room temperature. Wilmad SQ EPR tubes 
were used for EPR samples. Tubes containing 
protein solutions were quickly frozen in 
methanol kept on dry ice. Once frozen, 
samples were transferred to liquid nitrogen 
where they were stored prior to measurements. 
The spectra were measured on a Bruker EMX 
EPR spectrophotometer equipped with an 
Oxford Instruments liquid helium system. A 
spherical high quality Bruker resonator 
SP9703 was used. Temperature for all samples 
was 10 K. Microwave frequency and power for 





Static spectra- The spectrum of the CL 
complex of ferro cyt. c is shown in Fig 1. This 
spectrum has been assigned to a high spin 
pentacoordinate form of the heme (18). On 
binding NO to this complex, the broad Soret 
band of the ferrous form shifts to 394 nm and 
reduces in intensity and this is accompanied by 
small changes in the visible region. These 
spectral changes are consistent with NO (12) 
binding to the heme to generate a 
pentacoordinate NO adduct. The spectrum is 
reminiscent to the absorption spectra of NO-
bound guanylate cyclase (11), H93G 
myoglobin (23) and AXCP (12), indicating 
that the NO-bound form of the ferrous cyt. 
c/CL complex is 5-coordinated with neither the 
distal Met80 nor proximal His18 coordinated 
to the heme iron. This behaviour may be 
contrasted with that of cm cyt. c (spectra not 
shown) or the yeast variant Met80Ala mutant 
which binds NO, but yields a spectrum 
consistent with a hexacoordinate NO adduct 
(21).  
 These assignments are supported by 
the EPR spectra that are reported in the inset to 
Fig 1. The NO adduct of cm cyt. c (and of the 
Met80Ala mutant) show the typical “nine” line 
spectrum of the hexacoordinate species in 
which the unpaired electron on the NO couples 
to the histidine nitrogen that coordinates to the 
iron trans to the NO. In contrast to this, and 
consistent with the optical spectrum, the NO 
adduct of the CL complex of ferro cyt. c 
exhibits a “three” line spectrum and the nine 
line spectrum is absent, indicative of full 
histidine displacement from the heme. Under 
different experimental conditions, Vlasova et 
al. previously reported formation of a mixture 
of 5-coordinate and 6-coordinate cyt. c -NO 
complexes in the presence of CL (19). 
 Interestingly, the CL complex of cm 
cyt. c also shows a three line EPR spectrum 
highlighting that CL does more than just 
displace the Met80 from its coordination to the 
heme. 
We further investigated the 
reversibility of the process returning the CL 
pentacoordinate nitrosyl adduct to the native 
cyt. c protein. Following the removal of NO by 
photolysis in the presence of an NO scavenger, 
and the separation of CL from cyt. c by 
addition of salt/detergent and cation exchange 
chromatograhy, the spectrum of the resulting 
protein in its reduced form was identical to that 
of native ferro cyt. c (data shown in SI). This 
result provides clear evidence that the 
transition brought about by CL is fully 
reversible. This experiment is also fully 
consistent with our finding that addition of salt 
stops rebinding of CO after laser photolysis, i.e 
removal of CL returns the ferrous protein to its 
non CO binding native form (18) 
 
Stopped –flow experiments- On mixing the 
ferro cyt. c/CL adduct with excess NO a 
complex sequence of kinetic events was 
observed, in which a number of distinct 
spectral intermediates could be discerned. Fig 
2 shows the spectral evolution observed on 
mixing 15 µM NO with anaerobic ferro cyt. 
c/CL (2.5 µM cyt. c). The initial spectrum is 
captured 1.5 ms after mixing and thereafter a 
series of optical transitions takes place leading 
eventually, after approximately 20 s, to the 
final spectrum that is identical to that observed 
in static experiments (Fig 1). In Fig 2 a subset 
of the total data set collected is displayed. The 
data set was analysed using an SVD algorithm 
and spectra generated for a sequential pathway 
with five species (A to E, including the initial 
and final forms and three intermediates). These 
spectra are also given in Fig 2 together with 
the static (t=0) deoxy spectrum. 
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 The full time courses, displayed using 
a split time base at a single wavelength, 420 
nm, and at two NO concentrations are given in 
Fig 3. These time courses display the distinct 
phases that are temporally well separated. 
These phases and the putative assignments are 
now described in turn and for ease of 
understanding we refer also to the mechanism 
shown in Fig 4. 
 The first very rapid kinetic process 
(within the first 50 ms) is, at high NO 
concentrations, partially lost in the dead time 
of the apparatus (1 ms). However the shape of 
the difference spectrum (static minus first 
captured spectrum, A*) is identical to that of 
the difference spectrum (A* minus the 
spectrum recorded at 50 ms), data not shown. 
This indicates that no other spectral process 
was missed. The rate constant of this first step 
was NO concentration dependent. This step we 
therefore assign to the initial NO binding to the 
heme. Kinetic analysis yields a second order 
rate constant k1 of 2* 107 M-1 s-1, very much in 
line with rate constants of NO binding to many 
other heme proteins, but interestingly orders of 
magnitude higher than binding to AXCP (24) 
and ferro Met80Ala cyt. c (22) in which 
binding is rate limited by steric hindrance 
provided by the tightly packed protein cage. 
The spectral changes accompanying NO 
binding indicate that the primary binding 
process leads to a species that is similar to the 
final NO bound form and different from the 
NO adducts of cm cyt. c or the Met80X 
mutants that we have previously described (22) 
and shown to be hexacoordinate complexes 
(Fig 1) . Thus we propose that the initial NO 
binding reaction dissociates the proximal 
histidine ligand to yield a pentacoordinate 
species. We see no evidence of a transient 
hexacoordinate species and thus conclude that 
dissociation of the histidine, once NO is bound 
to the heme, is more rapid (< 1 ms) than the 
binding. 
 Following the initial binding reaction a 
slower step occurs, the rate of which is 
essentially NO concentration independent. The 
amplitude of this phase is influenced by the 
NO concentration but we attribute this to the 
behaviour of the subsequent step which more 
rapidly depletes this intermediate at high [NO], 
see later for details. Curiously, the second 
reaction takes the spectrum back towards that 
of the original spectrum, Fig 2. This finding 
appears most easily explained by the binding 
of an, as yet unidentified, intrinsic ligand trans 
to the bound NO. If this conjecture is correct, 
the form of the spectrum suggests that the 
ligand is likely to be a weak field ligand as the 
spectrum is more reminiscent of a high spin 
rather than a low spin heme species. 
 The third major step is the most 
surprising for a variety of reasons. Firstly this 
slow process is again NO concentration 
dependent, a remarkable feature given that 
second order processes in which NO binds to 
heme are generally very rapid. An important 
clue that may explain this phenomenon is that 
the time courses, especially at high NO 
concentrations, do not conform to 
exponentials. Rather, they are almost linear, 
typical of zero order steps (Fig 3). Such time 
courses are seen in ligand binding to heme 
when the rate limit in the process is not 
chemical but diffusion (see Discussion). The 
spectrum of the species at the end of this 
process is very similar to the final product and 
by comparison we assign this to a 
pentacoordinate heme NO adduct. 
 The last slow (k4 = 0.1 s-1), [NO] 
independent, step (D to E) takes the protein to 
the final NO adduct  that we see in the static 
experiments. 
The rate at which NO dissociates from 
the final complex was determined by mixing 
the NO adduct of the ferro cyt. c/CL complex  
with an excess of oxyhemoglobin, using the 
method described by Sarti et al (25). The 
simultaneous formation of met hemoglobin 
and ferric cyt. c was followed by taking spectra 
in the visible region at known time intervals. A 
single exponential process was observed with 
rate constant ~ 5* 10-4 s-1. 
 
Ultrafast spectroscopy- On exposing the NO 
adduct of the ferro cyt. c/CL complex to a 
femtosecond laser pulse, NO dissociates from 
the heme. The spectral evolution at selected 
delay times of the ferrous-NO cyt. c/CL 
complex is presented in Fig 5. The spectra are 
dominated by an induced absorption at 427 nm 
and the bleaching of the ground state at 394 
nm. Global analysis of the data reveals a very 
fast component (~2.8 ps) ascribed to excited 
state photophysics (26, 27) and a 7 ps 
component ascribed to NO geminate 
recombination (inset I). The latter component 
has the same spectral characteristics as the 7.5 
ps component of guanylate cyclase and 
corresponds to a 4-coordinated heme species 
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(28). The static absorption spectrum of the 4-
coordinated heme calculated as described in 
(29), is shown in inset II. Fitting of the kinetic 
trace at 427 nm (inset III) reveals that 11% of 
the NO does not rebind within 100 ps (i.e. the 
absorbance following photolysis falls from 10-2 
A to 1.1 x 10-3A, in 100 ps and only reaches 
zero in the ms time range). The remainder of 
the NO (89%) rebinds in a single exponential 
phase, indicating that NO remains close to the 
heme, without exploring multiple 
configurations in the heme pocket. The 
spectrum of the species remaining after the 7-
ps component is significantly red-shifted with 
respect to the spectrum of the rebinding phase 
(Fig 6B) and its extrema are similar to those of 
the steady state difference spectrum and the 
microsecond difference spectrum (see below). 
Therefore this spectrum is assigned to the 5-
coordinate His-bound species. Thus, upon NO 
dissociation, binding of proximal His occurs in 
direct competition with NO rebinding, and the 
intrinsic time constant of the process (yield 
~11%) is ~70 ps. No further spectral evolution 
takes place up to 4 ns, the longest time 
accessible with the instrument.  
 
Microsecond spectroscopy- The time courses 
observed following NO photo-dissociation 
from the ferro cyt. c/CL complex are shown in 
Fig 6 (inset) at two NO concentrations. These 
time courses conform to simple exponentials 
yielding first order rate constants of ~400 s-1 
that are [NO] concentration independent. The 
difference spectrum for the rebinding of NO, 
compiled by plotting the amplitude of these 
time courses as a function of wavelength, is 
given in Fig 6A where it is compared with the 
corresponding static difference spectrum (i.e. 
deoxy spectrum minus NO adduct spectrum). 
It is clear from Fig 6 that the kinetic and static 
difference spectra are identical, indicating that 
NO re-binding on this timescale is to a 
pentacoordinate heme that has histidine bound 
(see above). This accounts for the NO 
concentration independent binding kinetics 
which reflects replacement of the intrinsic 





The sequence of events that 
accompany NO binding to  ferro cyt. c/CL is 
complex and in several ways unexpected. 
Mechanisms for NO binding to AXCP have 
been reported with similar mechanistic steps, 
albeit characterised by rather different kinetics 
and some different experimentally observable 
intermediates. These mechanisms, supported 
by X-ray structural information, are framed in 
terms of NO binding to a pentacoordinate c 
type heme, histidine displacement from the co-
ordination site trans to the bound NO, binding 
of a second NO to the proximal site, from 
which the histidine has dissociated, to form a 
transient species in which two NO molecules 
are bound and finally the dissociation of the 
NO from the distal position, where the first NO 
bound, to form the final product, a 
pentacoordinate heme with NO bound at the 
proximal position (30, 31). We suggest that the 
spectral and kinetic data described above can 
best be understood in a related mechanistic 
framework, which is provided in Fig 4. The 
scheme is delineated to show both, those 
species seen in the stopped flow experiments 
and those seen in photolysis experiments. 
Species A we have characterised as a 
pentacoordinate ferrous form. The initial 
binding reaction with NO we represent as 
being to the empty distal side of the heme. This 
is the simplest hypothesis as the process is 
second order in NO and no other intermediates 
are seen. This is the site where CO binds. The 
spectrum of species B indicates that the 
intrinsic proximal histidine is dissociated on 
NO binding; we estimate a lower limit of the 
intrinsic rate constant of this process of ~103   
s-1. This process occurs orders of magnitude 
faster than in GC (32) and AXCP (33), where 
the proximal histidine is only dissociated upon 
binding of a second NO molecule, and a 
transient pentacoordinate species is not 
observed. This comparison points at a high 
structural flexibility at the proximal heme site 
in the cyt. c/CL complex, allowing the 
dissociated histidine to easily move away from 
the heme iron interaction zone.  
Subsequent to formation of the 
pentacoordinate species B a slower step leads 
to the formation of species C. Kinetics analysis 
(see Results) of this process as part of a 
sequential mechanism (A>E) indicates that the 
rate constant for the formation of C is 
essentially [NO] independent with a rate 
constant k2 of ~7 s-1. This step is therefore not 
assigned to binding of a second NO molecule. 
Furthermore this step, most easily discerned at 
low [NO], is accompanied by a distinct and 
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large change in spectrum, most readily 
explained by binding of a ligand to the heme to 
form a high spin species. There are a number 
of possibilities that may account for this 
spectrum. The most likely we suggest is 
binding of a weak field ligand to the empty 
proximal position of the heme. At present we 
are unable to identify this ligand or even to 
distinguish if it is an intrinsic amino acid 
residue or, for example, water. Such 6-
coordinate nitrosyl intermediate has not been 
observed in GC or AXCP, where the proximal 
histidine remains bound longer (see above). At 
physiological, low, NO concentrations, this 
intermediate can be very long lived and 
possibly play a direct role in NO release in 
mitochondria. 
Whatever the nature of this proximal ligand it 
appears to be displaced by a second NO 
molecule. The evidence for this conclusion 
comes from the strong dependence of the rate 
of formation of species D on [NO]. Two 
remarkable, but possible linked, features 
characterise this reaction. Firstly it is slow 
(timescale of a second), whereas binding of 
NO to ferrous heme is generally very rapid, 
secondly the time courses are, particularly at 
high [NO], not exponential but quasi-zero 
order typical for diffusive processes. In order 
to account for this behaviour we propose that 
on initial mixing of the protein/lipid complex 
with NO this ligand rapidly binds to the empty 
distal site. Although the proximal histidine 
dissociates, the site vacated is inaccessible to 
NO until the protein has undergone some 
rearrangement as indicated by the steps 
described above, i.e. a reorganisation allowing 
the binding of a ligand labelled X in Fig 4 
species C. NO in solution partitions into the 
considerable lipid phase that CL provides (30 
CL molecules/cyt. c). It is from this phase, 
comprising bi-lipid membrane fragments on to 
which the cyt. c is bound, that NO now 
diffuses to the site where it can displace the 
putative ligand designated X. The rate of this 
process will depend on the concentration 
gradient and thus on [NO] but the process will 
not conform to a chemical kinetic process with 
exponential time course. Similar behaviour has 
been described for CO combination with Hb in 
erythrocytes, rate limited by diffusion through 
the unstirred layer (34, 35). Clearly the access 
pathway of NO to the distal and to the 
proximal binding sites are very different in 
nature. 
Given that the rate depends on the [NO] 
gradient, it follows that at high [NO] the time 
course will maintain its linearity over the 
majority of the binding process because the 
[NO] gradient changes little, and at lower [NO] 
this linearity is lost as the gradient now 
decreases during the time course. Thus, the 
initial slopes of the curves are directly 
proportional to the [NO] but at, say, ~7.5 µM 
[NO] the gradient falls as the NO is bound to 
the iron, which at ~3 µM removes the 
equivalent NO from solution leaving only ~4.5 
µM free and thus a gradient of only ~1.5 µM . 
 If we ignore the non-exponential nature of the 
transition from C to D and assume that what 
we follow is not diffusion dependent but a 
reflection of the chemistry then there are a 
number of alternatives in assigning the relative 
values of rate constants. One alternative is that 
the formation of the dinitrosyl complex limits 
the overall processes and thus rate of the 
appearance of species D is [NO] dependent 
with second order rate constant of the order 104 
M-1 s-1, which is exceedingly small for NO 
binding to a ferrous heme, making this 
explanation unlikely in our view although not 
impossible. 
             The dominant feature of the transition 
from C to D is, therefore, the slow zero order 
phase. However, the situation may be more 
complex than described above. Simulations of 
the mechanism incorporating a zero order 
phase (not shown here), while reproducing the 
main features we observe do not fully model 
the change in amplitude in the signal assigned 
to the formation and decay of intermediate C 
seen on changing the [NO] from 30 to 60 µM. 
It is possible that there is a further component 
of the time course which is [NO] dependent 
and exponential and which is not therefore 
diffusion limited. For example, NO may access 
the heme site, in a fraction of the molecules at 
least, from the bulk solution and therefore 
display exponential kinetics. At high [NO] this 
process may effectively compete with the 
binding of the internal ligand (X in Fig 4 ) and 
lead to the formation of D without passing 
through C. It may also, at lower [NO], smooth 
the transition between the zero order phase and 
the slow transition leading to D.  
In agreement with Andrew et al (33), 
who report NO binding to AXCP, we suggest a 
putative di-nitrosyl complex is transiently 
formed from which NO at the distal site 
dissociates to leave a nitrosyl complex with a 
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single NO molecule bound at the proximal site. 
This is identical to the final product of NO 
binding to AXCP. Thus species D displays the 
spectrum typical for a pentacoordinate NO 
species and accounts for the similarity between 
the spectra of species D and B.  
 A final slow first order step associated` 
with a small spectral change leads to the final 
stable product seen statically, this product is 
labelled E in Fig 4 and is, as stated above, a 
pentacoordinated nitrosyl displaying optical 
and EPR spectra typical of such species. The 
nature of this final transition is presently 
unknown, but the small spectral changes are 
not compatible with ligand change at the iron 
and thus we suggest that it reflects some slow 
structural relaxation of the lipid/protein 
complex bringing the heme environment to its 
final equilibrium state. 
 Species E is the starting point for all 
photolysis experiments. Dissociation of NO 
from this yields a 4-coordinate species, F, the 
spectrum for this species (Fig. 5, Inset II) has 
been constructed from the absolute absorption 
of species E, i.e. the static spectrum of the NO 
complex (Fig 1) and the difference spectrum 
between species F and E given in Fig 5. 
Rebinding to F is largely geminate (89%) with 
a time constant typical for geminate 
recombination of NO to heme c of 8 ps (20). 
The remainder of the NO moves away from the 
heme, our data to date do not allow us to say 
whether this NO reaches the bulk phase or 
moves to sites removed from the heme but 
within the protein/lipid complex, but the latter 
seems the more likely (see below). 
Nevertheless, the fact that 11% of the NO does 
not rebind in the geminate phase may indicate 
a higher apparent quantum yield, φ, (fraction 
of NO dissociated leaving the heme pocket) for 
NO dissociation than is usual for heme 
proteins. In particular, it is much higher than in 
GC (~3%) (28) and AXCP (~1%) (31). The 
high probability of escape may be due to the 
very efficient and direct competition of His 
binding (τ=~60 ps). Indeed, recent experiments 
on AXCP indicate that in this protein no such 
direct competition exists and NO has to leave 
the heme environment before His can bind 
(36). Again, this comparison points at a 
flexible proximal binding environment of the 
heme in the cyt. c/CL complex, allowing for 
accommodation of both NO and His in the 
proximity of the heme iron. 
We also note that the relatively high φ 
for NO dissociation mirrors the high quantum 
yield for CO dissociation (φ=0.89) that we 
have reported for the cyt. c/CL complex (18).  
The binding of His yields species G, 
the pentacoordinate complex, to which NO 
recombines at the rate of the histidine 
dissociation (k7=400 s-1). The fact that NO re-
binding following photodissociation is rate 
limited at 400 s-1 while CO rebinding in similar 
experiments is not limited at this value and 
proceeds at high [CO] more rapidly (18), 
strongly supports the view that binding of NO 
is coupled to structural changes not 
encountered with CO and is consistent with 
these gaseous ligands rebinding to opposite 
faces of the heme group. 
 The final step (G to A) is added to 
counterbalance the slow “rearrangement” we 
have assigned to the transition within the 
nitrosyl complex from D to E, presuming that 
some similar step may occur in the deoxy 
ferrous state that we have been unable to see 
because we only form G following NO 
dissociation and this species is removed on 
recombination with NO following histidine 
replacement. The distinction between G and A 
also appears necessary if we are to explain the 
differences between NO binding seen in 
mixing or photolysis experiments (see below). 
 Given the complexities of the reaction 
we observe, and given the precedent of AXCP, 
we believe that the mechanism depicted in Fig. 
4 is the simplest that is consistent with all the 
data.  There are several questions that may 
legitimately be posed regarding this 
mechanism. Why, for example, given the 
seemingly similar structure of species A and G 
do they display such different NO binding 
profiles. We suggest an answer to this in terms 
of the NO moving, following dissociation from 
the proximal side, into the protein but being 
retained near the binding site. In this view, the 
400 s-1 NO rebinding formally corresponds to a 
geminate heme-NO rebinding process. We 
must also suppose that binding to the distal 
side in G is denied to the NO, at least in the 
time frame we monitor, by those structural 
changes that we assign to the D to E transition. 
It is also for this reason that we propose a 
transition between G and A in the scheme 
reversing the transition D to E and completing 
the thermodynamic cycle.  
The findings we report here 
demonstrate the remarkable influence CL 
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exerts on the ligand binding properties of cyt. c 
and in particular on ferro cyt. c which in the 
absence of CL does not bind CO and binds NO 
only very slowly. CL has been suggested to 
bind to cyt. c both through electrostatic 
interactions and through hydrophobic 
interactions between one of the aliphatic chains 
and a non polar cleft formed in the surface of 
the protein by the parallel strands of the 
polypeptide backbone (37). This interaction 
triggers significant structural alteration in the 
protein. Most obviously the Met80 residue is 
removed from coordination to the iron 
allowing facile NO (and CO) binding but over 
and above this, conformational changes are 
promoted that lead to the dissociation of the 
proximal histidine residue on NO binding (Fig 
1). This conversion of a hexacoordinate to a 
pentacoordinate heme nitrosyl complex on 
interaction with an “effector” finds parallels in 
the interaction of hemoglobin NO complexes 
with IHP (inositol hexaphoshate, a mimic of 
the in vivo effector 2,3 bis-phospho glycerate), 
where the proximal histidine in the α chains 
dissociates (38). It is unknown whether here 
NO binds to the proximal or distal side.  
The major conclusion that NO binds 
finally to the proximal position is surprising 
and may have important functional 
significance not only through modulating NO 
release in the mitochondria but also by 
interfering with the peroxidatic activity of 
protein. 
Our data also reveal that following 
photo-dissociation a significant fraction of the 
dissociated NO ligand escapes from the heme 
cavity of the cyt. c/CL complex. This is 
consistent with our previous studies on the CO 
dynamics of the cyt. c/CL complex that 
indicated that significant conformational 
changes occurred in cyt. c on interaction with 
CL resulting in heme pocket reorganisation 
coupled with dissociation of the intrinsic 
methionine heme ligand (18). This in itself 
may have important consequences as recent 
work has shown that disruption of the 
methionine to Fe ligation stimulates 
translocation of cyt. c to the cytoplasm and 
nucleus in non-apoptotic cells (39). In addition, 
we propose that NO binds to the heme through 
a complex mechanism that is in principle 
similar to that proposed for AXCP (31), but 
with a number of remarkable kinetic and 
intermediate differences, pointing in particular 
to a very flexible, yet confined, proximal heme 
‘pocket’. The functional consequences of this 
complex behaviour, were it to occur in vivo, 
are presently unclear, however, we may, by 
comparison with AXCP and guanylate cyclase, 
suggest that this behaviour may reflect a 
“kinetic trap “ mechanism for the release of 
NO from ferrous cyt. c/CL complex. In our 
experiments we have also identified a 
relatively long-lived pentacoordinate species 
with NO bound to the distal side. We do not 
know as yet the dissociation rate from this 
form but this form as well as the 
hexacoordinate NO-bound intermediate may 
also play a role in regulating NO release in 
mitochondria. Our work therefore implies that 
CL may contribute to a controlled NO release 
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Fig. 1. Spectra of cyt. c (native) and cm cyt. c. I, the dithionite reduced (deoxy) form of cyt. c; II, the 
deoxy form of cyt. c/CL; III, the deoxy form of cyt. c/CL/NO; IV, the deoxy form of cm cyt. c/NO. 
Conditions: [cyt. c]=8 µM, [CL]=240 µM, [NO]=100 µM. Inset, EPR  spectra of native and cm cyt. c 
(a) cm cyt. c + NO (the spectrum for Met80Ala cyt c + NO was identical) (b) cm cyt. c + CL + NO (c) 
cyt. c + CL + NO. Conditions: [cyt. c]=20 µM, [CL]=500 µM, [NO]=100 µM, temperature for all 
samples was 10 K, microwave frequency and power for all samples was 9.47 GHz and 3.18 mW 
respectively. 
 
Fig. 2. Stopped flow data for the mixing of the ferrous cyt. c/CL adduct with NO. A, shown is the 
static (t=0) deoxy spectra prior to mixing, and the time recorded spectra from ~1.5 ms after mixing to 
~50 ms (spectra shown every ~1.8 ms) and from 50 ms to ~20 s (spectra shown every ~300 ms). Time 
indications are given at ~1.5 ms, 20 ms, 200 ms, 2 s and 20 s. B, spectra A to E are from the global 
analysis of the stopped flow reaction between the ferrous cyt. c/CL adduct with NO (the static or t=0 s 
spectra is also given). Conditions: [cyt. c]=3 µM, [CL]=75 µM, [NO]=60 µM (all after mixing). 
 
Fig. 3. Shown are the time courses for the stopped flow reactions mixing the ferrous cyt. c/CL adduct 
with NO of different concentrations, followed at a single wavelength of 420 nm. Time is shown on an 
isometric scale. [NO]’s used were ~60 and 15 uM after mixing. Inset, the time courses of four separate 
mixing reactions, cyt. c/CL with different NO concentrations. Time is plotted on an isometric time 
scale ranging from 0.2 to 10 s. Conditions: [cyt. c]=3 µM, [CL]=75 µM, [NO]=7.5, 15, 30, and 60 µM 
all after mixing (i to iv respectively), temperature=220C, buffer used was 20 mM Hepes pH 7.4. 
 
Fig. 4. Scheme of intermediates in the reactions between the ferrous cyt. c/CL complex and NO. See 
text for details. * This reaction is a zero-order reaction with a rate (∆[cyt. c]/s.) proportional to the NO 
concentration. This observation may be expressed by incorporating the [NO] dependence into the “rate 
constant”. Thus, the “rate constant” may be written (∆[cyt. c]/s)/[NO] which therefore has the units of 
s-1, as given in the scheme. 
 
Fig. 5. Ultrafast spectroscopy of the ferrous-NO cyt. c/CL adduct. The spectral evolution at selected 
delay times of the ferrous-NO cyt. c/CL adduct upon photodissociation of the NO is presented as a 
series of difference spectra using the spectrum of the NO form as a baseline. Inset I, spectral 
contribution of a 7 ps component (see Results for assignment). Inset II, the calculated static absorption 
spectrum of the 4-coordinated heme calculated (see Results for assignment). Inset III, a fit to the 
kinetic trace at 427 nm.  
    
Fig. 6. A, Microsecond spectroscopy of the ferrous-NO cyt. c/CL adduct. The line represents the 
difference spectrum obtained from the steady state species, the spectrum of the deoxy ferrous cyt. 
c/CL complex minus the spectrum of the NO adduct. The circles represent the difference spectrum 
constructed (375-450 nm, every 5 nm inclusive) on photodissociation of NO from its adduct with cyt. 
c/CL. At each wavelength, the total change in absorbance for each time course was plotted (=deoxy 
minus NO). This difference spectrum (by flash) is normalised (~x3) to the steady state one. Inset, time 
courses following flash photolysis of NO from its adduct with cyt. c/CL monitored at 420 nm and at 
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two different NO concentrations 20 and 100 µM (offset for clarity) (similar results for 500 µM). B. I, 
the difference spectrum obtained from the steady state spectra of ferrous cyt. c/CL minus the spectra of 
the NO adduct (same as A, line). This spectrum has been multiplied by 0.2 to normalise it with spectra 
II and III. II, the difference spectrum constructed of the 4-coordinate species corresponding to the 7-
ps rebinding phase inset I. III, the spectrum of the long-lived phase, assigned to 5-coordinate His-
bound heme. 
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k1=2*107 M-1 s-1 k2=7 s-1
k3=0.1 s-1*
k4= 0.1 s-1
k5=1.3*1011 s-1 (τ=8 ps)
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